Macquarie Group
BPMC

Macquarie Group’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$118M Sell
922,167
-364,730
-28% -$46.8M 0.15% 182
2025
Q1
$114M Buy
1,286,897
+27,921
+2% +$2.47M 0.14% 199
2024
Q4
$110M Sell
1,258,976
-4,685
-0.4% -$409K 0.13% 217
2024
Q3
$117M Sell
1,263,661
-48,406
-4% -$4.48M 0.13% 221
2024
Q2
$141M Buy
1,312,067
+829
+0.1% +$89.4K 0.16% 165
2024
Q1
$124M Sell
1,311,238
-257,709
-16% -$24.4M 0.14% 186
2023
Q4
$145M Sell
1,568,947
-10,895
-0.7% -$1M 0.17% 157
2023
Q3
$79.3M Buy
1,579,842
+61,756
+4% +$3.1M 0.1% 270
2023
Q2
$95.9M Buy
1,518,086
+20,700
+1% +$1.31M 0.11% 243
2023
Q1
$67.4M Buy
1,497,386
+186,636
+14% +$8.4M 0.08% 326
2022
Q4
$57.4M Buy
1,310,750
+24,161
+2% +$1.06M 0.07% 399
2022
Q3
$84.8M Buy
1,286,589
+11,700
+0.9% +$771K 0.1% 272
2022
Q2
$64.4M Buy
1,274,889
+41,961
+3% +$2.12M 0.07% 370
2022
Q1
$78.8K Sell
1,232,928
-43,834
-3% -$2.8K 0.06% 373
2021
Q4
$137M Sell
1,276,762
-18,656
-1% -$2M 0.11% 237
2021
Q3
$133M Buy
1,295,418
+134,967
+12% +$13.9M 0.11% 234
2021
Q2
$102M Buy
1,160,451
+318,833
+38% +$28M 0.08% 297
2021
Q1
$81.8M Buy
841,618
+7,415
+0.9% +$721K 0.12% 211
2020
Q4
$93.6M Buy
834,203
+73,638
+10% +$8.26M 0.14% 166
2020
Q3
$70.5M Buy
760,565
+563,027
+285% +$52.2M 0.12% 186
2020
Q2
$15.4M Buy
197,538
+169,374
+601% +$13.2M 0.03% 533
2020
Q1
$1.65M Buy
28,164
+15,666
+125% +$916K ﹤0.01% 968
2019
Q4
$1M Sell
12,498
-105,060
-89% -$8.41M ﹤0.01% 1242
2019
Q3
$8.64M Buy
+117,558
New +$8.64M 0.01% 634